FDA Inspection 967549 — Summit Surgical Corp.

Summit Surgical Corp. — FEI 3011420259

The FDA completed an inspection of Summit Surgical Corp. on April 13, 2016 in Renton, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 13, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Renton, WA (United States)